Research Guide
A practical framework for biotech valuation
Biotech valuation is a probability-weighted reading of clinical risk, market size, competitive positioning, financing needs, and strategic value. The goal is not precision for its own sake, but a disciplined map of assumptions.
What to check first
Start with the evidence that can change value: clinical relevance, regulatory path, competitive context, financing needs, and whether the company can reach the next milestone.
How Drugnews uses this guide
We apply these frameworks when writing company research, paid analysis, and client-facing content so that readers can follow the logic behind each judgment.